Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results. Trump is guilty of mortgage ...

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

Corteva Agriscience is expanding its focus on biological crop protection in India, targeting biocontrols and biostimulants to address climate challenges and pest resistance. The company views India as ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Inside the station, every surface was wrapped with more of its ads—babies on turnstiles, on staircases, on banners overhead. “Think about it. Makeup and then genetic optimization,” exulted Kian ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

For CPG brands already navigating evolving standards around transparency, sustainability and ingredient innovation, gene ...

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...